ADMA Biologics, Inc. (ADMA)
9.70
-0.24
(-2.41%)
USD |
NASDAQ |
Apr 10, 16:00
9.75
+0.05
(+0.52%)
After-Hours: 20:00
ADMA Biologics EPS Diluted (Quarterly) : 0.2025 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Inovio Pharmaceuticals, Inc. | 0.0546 |
| ANI Pharmaceuticals, Inc. | 1.172 |
| AtriCure, Inc. | 0.0366 |
| Ligand Pharmaceuticals, Inc. | 2.119 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 49.38M |
| Revenue (Quarterly) | 139.16M |
| Total Expenses (Quarterly) | 89.78M |
| Enterprise Value | 2.302B |
| Gross Profit Margin (Quarterly) | 63.78% |
| Profit Margin (Quarterly) | 35.48% |
| Earnings Yield | 6.18% |
| Operating Earnings Yield | 8.04% |
| Normalized Earnings Yield | 6.273 |